Literature DB >> 3606937

Specificity of the inhibitory effect of dextropropoxyphene on oxidative drug metabolism in man: effects on theophylline and tolbutamide disposition.

R A Robson, J O Miners, A G Whitehead, D J Birkett.   

Abstract

Two groups of six healthy male volunteers were studied to assess the possibility of an interaction between dextropropoxyphene and theophylline or tolbutamide using a randomised, crossover design. Subjects received theophylline 125 mg 8 hourly or tolbutamide 500 mg i.v. with and without dextropropoxyphene hydrochloride 65 mg 8 hourly. Theophylline 8-hydroxylation was reduced by a mean of 17% but there were no changes in theophylline 1-demethylation, theophylline 3-demethylation or tolbutamide hydroxylation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3606937      PMCID: PMC1386175          DOI: 10.1111/j.1365-2125.1987.tb03115.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  The effect of cimetidine on tolbutamide kinetics.

Authors:  N G Dey; C M Castleden; J Ward; J Cornhill; A McBurney
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

2.  Differential effects of cimetidine on theophylline metabolic pathways.

Authors:  J J Grygiel; J O Miners; R Drew; D J Birkett
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  The effect of sulphinpyrazone on oxidative drug metabolism in man: inhibition of tolbutamide elimination.

Authors:  J O Miners; T Foenander; S Wanwimolruk; A S Gallus; D J Birkett
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Interaction of propoxyphene with carbamazepine.

Authors:  M Dam; J Christiansen
Journal:  Lancet       Date:  1977-09-03       Impact factor: 79.321

5.  Noncompartmental determination of the steady-state volume of distribution.

Authors:  L Z Benet; R L Galeazzi
Journal:  J Pharm Sci       Date:  1979-08       Impact factor: 3.534

6.  Comparison of theophylline and theobromine metabolism in man.

Authors:  D J Birkett; R Dahlqvist; J O Miners; A Lelo; B Billing
Journal:  Drug Metab Dispos       Date:  1985 Nov-Dec       Impact factor: 3.922

7.  Cigarette smoking and theophylline clearance and metabolism.

Authors:  J J Grygiel; D J Birkett
Journal:  Clin Pharmacol Ther       Date:  1981-10       Impact factor: 6.875

8.  Interaction of propoxyphene with diazepam, alprazolam and lorazepam.

Authors:  D R Abernethy; D J Greenblatt; D S Morse; R I Shader
Journal:  Br J Clin Pharmacol       Date:  1985-01       Impact factor: 4.335

9.  Pharmacogenetics of tolbutamide metabolism in humans.

Authors:  J Scott; P L Poffenbarger
Journal:  Diabetes       Date:  1979-01       Impact factor: 9.461

10.  Influence of dextropropoxyphene on steady state serum levels and protein binding of three anti-epileptic drugs in man.

Authors:  B S Hansen; M Dam; J Brandt; E F Hvidberg; H Angelo; J M Christensen; P Lous
Journal:  Acta Neurol Scand       Date:  1980-06       Impact factor: 3.209

View more
  3 in total

Review 1.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

Review 2.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

Review 3.  Cytochrome P4502C9: an enzyme of major importance in human drug metabolism.

Authors:  J O Miners; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1998-06       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.